P184 - Profil lipidique du diabétique à l’hôpital général de référence nationale de Ndjamena

Dionadji, Mbainguinam; Abba, Ousman Mahamat; Lodoum, M.

doi:10.1016/s1262-3636(11)70810-2

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, we obtained significantly high mean LDLc levels among type I diabetics compared to the type II and non-diabetic controls (P=0.017). This is in line with several studies which recorded similar results and suggesting that LDL cholesterol represents the principal cardiovascular risk factor in the management of dyslipidemias among type I diabetics (Aqeella and Javaid, 2008;Dionadji et al, 2011). Also we recorded the prevalence of mixed dyslipidemias at 37.1% and 6.7% among type II diabetics and non-diabetics respectively.…”

Section: Lipid Profile and Cardiovascular Disease Risksupporting

confidence: 92%

Comparison of lipid profiles and 10 year cardiovascular disease risk estimates between indigenous northern diabetic and non-diabetic persons in Adamawa region, Cameroon

Pancha¹,

Damdam²,

Tamanji³

2016

J. Med. Biomed. Sci.

View full text Add to dashboard Cite

Dyslipidemias are possible debilitating outcomes of diabetes and important predictors of cardiovascular disease risk in diabetic patients. We carried out a cross-sectional, case control study from April to July 2014 at the Ngaoundere Regional Hospital involving 90 patients: 45 diabetics (10 type 1 and 35 type 2) and 45 non-diabetics with the aim of characterizing and comparing the lipid profile between type 1 and type 2 diabetics of northern Cameroon. Blood pressure and anthropometric measurements were obtained, and a fasting blood sample collected per patient on which blood sugar level and lipid profile were determined. Data analysis was performed using R Version 2.13.0 and the French version of Epi Info 7, with the level of significance set at 5%. Following threshold standards according to ANAES, the mean triglyceride level was significantly higher in type 2 diabetics (212.65±49.34 mg/dL) compared to type 1 diabetics (101.60±52.64 mg/dL) and controls (152.24±57.91 mg/dL) (p<0.0014). The mean low density lipoprotein (LDLc) was observed to be significantly higher in type 1 (136.78± 33.88 mg/dL) compared to type 2 (113.29 ± 38.00 mg/dL) diabetics and controls (94.62 ± 51.31 mg/dL) (P = 0.017), and likewise the median high density lipoprotein (HDLc) of type I, type II, and non-diabetics corresponding to 11.5, 47 and 56 mg/dl respectively were significantly different (p<0.0001). Furthermore, mixed hyperlipidemia was absent among the type 1 diabetics but more prevalent in type 2 diabetics (37.1 %) compared to controls (6.7%). According to the D’Agostino (Framingham) model, 37.1% of type II diabetics and 6.8 % of non-diabetics had a high risk of developing cardiovascular disease in 10 years, and the difference here was statistically significant (p=0.001). Both type 1 and type 2 diabetics originating from northern Cameroon are very prone to dyslipidemias and thus highly predisposed to cardiovascular diseases.Journal of Medical and Biomedical Sciences (2015) 4(3), 18-24Keywords: Diabetes, Lipid Profile, Cardiovascular disease risk, Northern Cameroon

show abstract

Section: Lipid Profile and Cardiovascular Disease Risksupporting

confidence: 92%

Comparison of lipid profiles and 10 year cardiovascular disease risk estimates between indigenous northern diabetic and non-diabetic persons in Adamawa region, Cameroon

Pancha¹,

Damdam²,

Tamanji³

2016

J. Med. Biomed. Sci.

View full text Add to dashboard Cite

show abstract

“…The 60 -69 age group was more representative (37.32%, n = 134). Thirteen patients (13) were under 40, i.e.…”

Section: Epidemiological Aspectsmentioning

confidence: 99%

“…In a recent study, Dioum et al [10] found a frequency of 9.0% among cardiology inpatients. Donadji et al found a much lower hospital frequency of 3.98% in Ndjamena [13]. In Senegal in 2002, Charles et al, in their study of elderly diabetics at the same center, found macro angiopathy in 30% of cases [14].…”

Section: Epidemiological Aspectsmentioning

confidence: 99%

See 1 more Smart Citation

Diabetic Macroangioapathy at the Internal Medicine Department of the Abass Ndao Hospital Center (About 359 Cases)

Djiby,

Boundia,

Assane

et al. 2024

JDM

View full text Add to dashboard Cite

Introduction: Macroangiopathy plays an important role, with a high prevalence of morbidity and mortality in diabetic patients. The aim was to study the epidemiological, clinical, paraclinical, therapeutic and evolutionary profile of macroangiopathy in diabetic patients in the internal medicine department of the Abass Ndao hospital. Patients and methods: This was a descriptive and analytical cross-sectional study. Our investigations were recruited over a 7-year period (January 1, 2016 to December 31, 2022). Results: Three hundred and fifty-nine (359) patients (10.22%) were enrolled. The mean age was 62.83 years, with extremes ranging from 17 to 98 years. The [60 -69] age group was more representative (37.32%). Women accounted for 180 cases (50.1%), with a sex ratio (m/f) of 0.99. The average duration of diabetes was 11.86 years. Average consultation time was 38.07 days, with extremes ranging from 1 to 368 days. Average hospital stay was 7.65 days. Inaugural diabetes was noted in 12 cases (3.34%). Type 2 diabetes accounted for 95.82% (n = 344) of patients. Hypertension was present in 150 patients (41.8%). Patients with 2 risk factors accounted for 173 cases (48.18%). Nineteen patients had already had a stroke (5.29% of cases). Fourteen ( 14) patients (4.2%) were amputees. Obliterative arteriopathy of the lower limbs (AOMI) was noted in 193 patients (54%). Stroke was noted in 101 patients (28%). Ischemic heart disease (IHD) was noted in 38 patients (11%). AOMI was more common in males (110 patients, 57%) than in females (43%). Seventy-three (73) patients (20.3%) died. Predictors of death were age over 60 and the existence of more than two cardiovascular risk factors. Conclusion: Diabetic macroangiopathy is a major cause of morbidity and mortality. The development and implementation of a prevention and management program is essential.

show abstract

Prévalence des dyslipidémies au laboratoire de biochimie du CHU la Référence Nationale de N'Djamena/Tchad

Mahamat-Azaki,

Zakaria,

Ali

et al. 2023

Annales de Cardiologie et d'Angéiologie

View full text Add to dashboard Cite

P184 - Profil lipidique du diabétique à l’hôpital général de référence nationale de Ndjamena

Cited by 3 publications

References 0 publications

Comparison of lipid profiles and 10 year cardiovascular disease risk estimates between indigenous northern diabetic and non-diabetic persons in Adamawa region, Cameroon

Comparison of lipid profiles and 10 year cardiovascular disease risk estimates between indigenous northern diabetic and non-diabetic persons in Adamawa region, Cameroon

Diabetic Macroangioapathy at the Internal Medicine Department of the Abass Ndao Hospital Center (About 359 Cases)

Prévalence des dyslipidémies au laboratoire de biochimie du CHU la Référence Nationale de N'Djamena/Tchad

Contact Info

Product

Resources

About